Gutiérrez Marcelino, Suyama Takashi L, Engene Niclas, Wingerd Joshua S, Matainaho Teatulohi, Gerwick William H
Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, California 92093, USA.
J Nat Prod. 2008 Jun;71(6):1099-103. doi: 10.1021/np800121a. Epub 2008 Apr 30.
Cancer cell toxicity-guided fractionation of extracts of the Papua New Guinea marine cyanobacteria Lyngbya majuscula and Lyngbya sordida led to the isolation of apratoxin D (1). Compound 1 contains the same macrocycle as apratoxins A and C but possesses the novel 3,7-dihydroxy-2,5,8,10,10-pentamethylundecanoic acid as the polyketide moiety. The planar structures and stereostructures of compound 1 were determined by extensive 1D and 2D NMR and MS data analyses and by comparison with the spectroscopic data of apratoxins A and C. Apratoxin D (1) showed potent in vitro cytotoxicity against H-460 human lung cancer cells with an IC 50 value of 2.6 nM.
对巴布亚新几内亚海洋蓝藻巨大鞘丝藻(Lyngbya majuscula)和污鞘丝藻(Lyngbya sordida)提取物进行癌细胞毒性导向分级分离,从而分离出了阿普拉毒素D(1)。化合物1与阿普拉毒素A和C含有相同的大环,但具有新型的3,7 - 二羟基 - 2,5,8,10,10 - 五甲基十一烷酸作为聚酮部分。通过广泛的一维和二维核磁共振及质谱数据分析,并与阿普拉毒素A和C的光谱数据进行比较,确定了化合物1的平面结构和立体结构。阿普拉毒素D(1)对H - 460人肺癌细胞显示出强大的体外细胞毒性,IC50值为2.6 nM。